Myriad Genetics reported $0 in Debt for its first fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Debt Change
Accelerate Diagnostics AXDX:US 116.08M 8.02M
Agilent A:US $ 2905M 175M
Becton, Dickinson and BDX:US $ 18635M 1211M
Bio Rad Laboratories BIO:US $ 1197.24M 1186.24M
Biocept BIOC:US $ 2.24M 0.27M
Bruker BRKR:US $ 1216.4M 117.8M
Danaher DHR:US $ 21778M 398M
Exact Sciences EXAS:US $ 2199.68M 0.75M
Fluidigm FLDM:US $ 100.03M 28.98M
Hologic HOLX:US $ 3093.1M 0.2M
Illumina ILMN:US $ 1740M 45M
Johnson & Johnson JNJ:US $ 33148M 603M
Mettler Toledo International MTD:US 1.87B 190.15M
Myriad Genetics MYGN:US $ 0M 0M
Nanostring Technologies NSTG:US $ 225.51M 0.37M
Orasure Technologies OSUR:US $ 2.91M 0.02M
Pacific Biosciences Of California PACB:US $ 896.22M 0.15M
Perkinelmer PKI:US $ 4867.71M 116.27M
Quest Diagnostics DGX:US $ 3987M 25M
Quidel QDEL:US $ 0M 0M
Repligen RGEN:US $ 283.27M 28.01M
Thermo Fisher Scientific TMO:US $ 33255M 1615M
Veracyte VCYT:US $ 1.68M 0.05M
Waters WAT:US $ 1444.12M 69.75M